XO Life connects patients and pharmaceutical companies through digital health and drug safety platforms.
Founded in 2018, XO Life provides a real-world evidence platform where patients share information about therapies and health conditions, along with software for pharmaceutical drug safety data. The company is based in Munich, Germany. In August 2024, it raised EUR 7 million co-led by Sandwater and Grazia Equity, with participation from Aescuvest, Winning Mindset Ventures, Isartal Ventures, MediVentures, capacura, Vi Partners, Bayern Kapital and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in